Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Shares Outstanding (Entity) of $66.9 million for Q4 2025, up 495.89% year-over-year from $11.2 million in Q4 2024, and down 30.48% quarter-over-quarter from $96.3 million in Q3 2025.
Cabaletta Bio (CABA) Shares Outstanding (2018 - 2026) Analysis & Trends
Cabaletta Bio's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $66.9 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 495.89% year-over-year to $66.9 million; the TTM figure through Dec 2025 stood at $66.9 million (up 495.89% YoY), while the FY2025 annual figure was $66.9 million, up 495.89% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $66.9 million, down from $96.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $96.3 million in Q3 2025, with the low at $507884.0 in Q2 2024.
- The 5-year median for Shares Outstanding (Entity) is $10.5 million (2024), against an average of $22.5 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) tumbled 93.62% in 2023, then soared 12083.21% in 2025.
- Cabaletta Bio's Shares Outstanding (Entity) stood at $4.3 million in 2021, then jumped by 41.25% to $6.0 million in 2022, then soared by 35.38% to $8.1 million in 2023, then jumped by 37.96% to $11.2 million in 2024, then surged by 495.89% to $66.9 million in 2025.
- Business Quant data shows CABA's Shares Outstanding (Entity) at $66.9 million in Q4 2025, $96.3 million in Q3 2025, and $61.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 151.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 151.16 Mn |
| Dec 31, 2025 | 66.93 Mn |
| Sep 30, 2025 | 102.26 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Mar 31, 2025 | 14.07 Mn |
| Dec 31, 2024 | 11.23 Mn |
| Jun 30, 2024 | 507,884.00 |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 7.95 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Jun 30, 2022 | 25.40 Mn |
| Mar 31, 2022 | 6.09 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 21.53 Mn |
| Jun 30, 2021 | 20.42 Mn |
| Mar 31, 2021 | 4.24 Mn |